WNX - Ticker AI Digest

Wellnex Life Limited 📰 1
Desk Snapshot GO VIP Login
Important AI Risk Notice

Charts, catalyst summaries, AI scores, forecasts and price context are AI-driven and can hallucinate, lag or miss market-changing information.

Not investment advice. Markets can move fast and any trade or allocation decision remains your responsibility.
AI can hallucinate. Summaries, rankings, forecasts and commentary can be wrong, incomplete or misleading.
AI-driven data only. Signals, dates, prices, sentiment and automation outputs may be delayed, estimated or stale.
Always verify externally. Confirm prices, filings, broker notes and trade setup details with independent sources before acting.
Mobile Command Deck
Wellnex Life Limited in one cleaner mobile flow.
Tap straight into the module you want. No sideways tab hunt, just a clean route into charts, news, Today’s AI, and the deeper desks.
WNX Data 2026-01-29 Preview Mode
Core Deck
Deep Dive Modules

Digested News

Today's Catalysts (WNX) 1
WNX 06:01
Wellnex Life Limited
Q2 FY26 Quarterly Update and Appendix 4C
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary of Wellnex Life Limited Q2 FY26 Quarterly Update and Appendix 4C**
Wellnex Life Limited (ASX/AIMWNX) released its Q2 FY26 quarterly update and Appendix 4C on January 29, 2026, highlighting significant operational and financial improvements. Key takeaways include
1. **Financial Performance**
Operating cash outflow improved to $(0.16) million, a substantial reduction from $(2.98) million in Q1 FY26, driven by 31.5% quarter-on-quarter (QoQ) revenue growth and cost-cutting measures.
Customer cash receipts rose to $5.10 million, up from $4.54 million in Q1 FY26.
Total revenue increased to $7.1 million, with IP Licensing revenue surging by 1,000% to $3.3 million, offsetting a 25.5% decline in Brands revenue to $3.8 million due to strategic consolidation of non-core assets.
Gross profit grew by 16.7% to $2.1 million.
2. **Cash Position**
Quarter-end cash balance increased to $0.98 million, with $2.01 million in undrawn financing facilities available.
Total financing facilities stood at $11.65 million, with $9.65 million drawn.
3. **Strategic Focus**
The company continues its turnaround strategy, focusing on core brands like Pain Away, improving cash conversion, and strengthening the balance sheet.
Manufacturing and operating cash flows normalized after a one-off raw material purchase in Q1 FY26.
4. **Corporate Updates**
Payments of $0.36 million were made to related parties for directors fees, executive remuneration, and associated costs.
The Board remains optimistic about execution and engagement across the business, with efforts to enhance margins and reduce costs.
5. **Investor Engagement**
Executive Chairman Ash Vesali will host a live investor briefing on February 2, 2026, at 11 am (AEDT).
6. **Appendix 4C Highlights**
Net cash from operating activities improved to $(0.16) million.
Financing activities contributed $0.965 million in net cash.
Estimated cash available for future operations is $2.98 million, sufficient for approximately 18.3 quarters based on current cash outflows.
Wellnex Life remains committed to its strategic goals, with a focus on profitability and sustainable growth.
Below is an HTML table comparing the financials and debt year on year based on the provided text. The table includes key metrics such as revenue, gross profit, cash balance, and debt levels for Q2 FY26 and Q1 FY26.
MetricQ2 FY26Q1 FY26% Change
Revenue
Brands$3.8 million$5.1 million(25.5%)
IP Licensing$3.3 million$0.3 million1000%
Total Revenue$7.1 million$5.4 million31.5%
Gross Profit$2.1 million$1.8 million16.7%
Operating Cash Flow$(0.16) million$(2.98) million94.6% Improvement
Customer Cash Receipts$5.10 million$4.54 million12.3%
Cash Balance (Quarter End)$0.98 millionNot ProvidedN/A
Total Debt Drawn$9.65 millionNot ProvidedN/A
Unused Financing Facilities$2.01 millionNot ProvidedN/A
### Notes: 1. **Year-on-Year Comparison**: The provided text only includes data for Q2 FY26 and Q1 FY26, so a full year-on-year comparison is not possible. The table compares the two quarters instead. 2. **Debt and Cash Balance**: The debt and cash balance figures are based on the information provided in the Appendix 4C and the main text. 3. **Percentage Changes**: Calculated based on the available data for Q2 FY26 and Q1 FY26. This table provides a clear comparison of key financial metrics between Q2 FY26 and Q1 FY26, highlighting improvements and changes in revenue, cash flow, and debt levels.
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 1
WNX 06:56
Wellnex Life Limited
Director/PDMR Shareholding
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 0
No items for this category on selected date.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 0
No items for this category on selected date.
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 2
WNX 06:01
Wellnex Life Limited
Q2 FY26 Quarterly Update and Appendix 4C
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary of Wellnex Life Limited Q2 FY26 Quarterly Update and Appendix 4C**
Wellnex Life Limited (ASX/AIMWNX) released its Q2 FY26 quarterly update and Appendix 4C on January 29, 2026, highlighting significant operational and financial improvements. Key takeaways include
1. **Financial Performance**
Operating cash outflow improved to $(0.16) million, a substantial reduction from $(2.98) million in Q1 FY26, driven by 31.5% quarter-on-quarter (QoQ) revenue growth and cost-cutting measures.
Customer cash receipts rose to $5.10 million, up from $4.54 million in Q1 FY26.
Total revenue increased to $7.1 million, with IP Licensing revenue surging by 1,000% to $3.3 million, offsetting a 25.5% decline in Brands revenue to $3.8 million due to strategic consolidation of non-core assets.
Gross profit grew by 16.7% to $2.1 million.
2. **Cash Position**
Quarter-end cash balance increased to $0.98 million, with $2.01 million in undrawn financing facilities available.
Total financing facilities stood at $11.65 million, with $9.65 million drawn.
3. **Strategic Focus**
The company continues its turnaround strategy, focusing on core brands like Pain Away, improving cash conversion, and strengthening the balance sheet.
Manufacturing and operating cash flows normalized after a one-off raw material purchase in Q1 FY26.
4. **Corporate Updates**
Payments of $0.36 million were made to related parties for directors fees, executive remuneration, and associated costs.
The Board remains optimistic about execution and engagement across the business, with efforts to enhance margins and reduce costs.
5. **Investor Engagement**
Executive Chairman Ash Vesali will host a live investor briefing on February 2, 2026, at 11 am (AEDT).
6. **Appendix 4C Highlights**
Net cash from operating activities improved to $(0.16) million.
Financing activities contributed $0.965 million in net cash.
Estimated cash available for future operations is $2.98 million, sufficient for approximately 18.3 quarters based on current cash outflows.
Wellnex Life remains committed to its strategic goals, with a focus on profitability and sustainable growth.
Below is an HTML table comparing the financials and debt year on year based on the provided text. The table includes key metrics such as revenue, gross profit, cash balance, and debt levels for Q2 FY26 and Q1 FY26.
MetricQ2 FY26Q1 FY26% Change
Revenue
Brands$3.8 million$5.1 million(25.5%)
IP Licensing$3.3 million$0.3 million1000%
Total Revenue$7.1 million$5.4 million31.5%
Gross Profit$2.1 million$1.8 million16.7%
Operating Cash Flow$(0.16) million$(2.98) million94.6% Improvement
Customer Cash Receipts$5.10 million$4.54 million12.3%
Cash Balance (Quarter End)$0.98 millionNot ProvidedN/A
Total Debt Drawn$9.65 millionNot ProvidedN/A
Unused Financing Facilities$2.01 millionNot ProvidedN/A
### Notes: 1. **Year-on-Year Comparison**: The provided text only includes data for Q2 FY26 and Q1 FY26, so a full year-on-year comparison is not possible. The table compares the two quarters instead. 2. **Debt and Cash Balance**: The debt and cash balance figures are based on the information provided in the Appendix 4C and the main text. 3. **Percentage Changes**: Calculated based on the available data for Q2 FY26 and Q1 FY26. This table provides a clear comparison of key financial metrics between Q2 FY26 and Q1 FY26, highlighting improvements and changes in revenue, cash flow, and debt levels.
WNX 06:01
Wellnex Life Limited
Market Update
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary**
Wellnex Life Limited (ASX/AIMWNX) released a market update on January 16, 2026, highlighting significant financial and operational improvements in the first half of FY26 (H1 FY26). Key achievements include
1. **Financial Performance**
H1 FY26 EBITDA improved by $2.4 million compared to the prior year.
Gross margin increased from 22.8% to 31.3%.
December 2025 EBITDA rose by $0.7 million year-on-year, driven by reduced operating costs.
The company operated at breakeven by the end of Q2 FY26.
2. **Pain Away Brand**
Quarterly sales in Q2 FY26 reached $3.3 million, with a 7.6% improvement in gross margin.
Market share gains in Australia, with heat patches and roll-ons outperforming category growth.
New distribution partnerships secured, including Priceline and major pharmacy wholesalers, with upcoming launches at Costco Australia and New Zealand.
3. **Operational Focus**
Simplified operations and cost discipline measures have stabilized the business.
Contract manufacturing is being optimized for better productivity and sustainability.
4. **Outlook**
Wellnex enters H2 FY26 with improved stability and a clear turnaround trajectory.
The company remains focused on consistent performance and long-term shareholder value creation.
Executive Chairman Ash Vesali emphasized the company’s progress and commitment to sustainable growth, positioning Wellnex for continued success in 2026.
Below is the HTML table code comparing the financials and debt year-on-year based on the provided text. Since the text does not explicitly mention debt figures, the table focuses on the financial metrics provided (EBITDA, Gross Margin, and Pain Away Sales).
MetricH1 FY26H1 FY25ChangeDecember 2025December 2024Change
EBITDAImproved by $2.4 millionNot specified+$2.4 millionUp $0.7 millionNot specified+$0.7 million
Gross Margin31.3%22.8%+8.5%Not specified (improvement sustained from November 2025)
Pain Away Sales (Q2)$3.3 millionNot specifiedNot specifiedNot specified (gross margin improved by 7.6%)
Operating Position (Q2 FY26)BreakevenNot specifiedNot specified
### Notes: 1. **Debt**: The provided text does not include specific debt figures, so the table omits debt comparisons. 2. **Metrics**: The table includes EBITDA, Gross Margin, Pain Away Sales, and Operating Position as these are the key financial metrics mentioned in the text. 3. **Changes**: Where specific numerical changes are provided (e.g., EBITDA improvement of $2.4 million), they are included in the table. 4. **Not Specified**: Fields marked "Not specified" indicate that the prior year's data or specific comparison is not provided in the text. This table can be directly embedded into an HTML document for display.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 3
WNX 06:01
Wellnex Life Limited
Q2 FY26 Quarterly Update and Appendix 4C
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary of Wellnex Life Limited Q2 FY26 Quarterly Update and Appendix 4C**
Wellnex Life Limited (ASX/AIMWNX) released its Q2 FY26 quarterly update and Appendix 4C on January 29, 2026, highlighting significant operational and financial improvements. Key takeaways include
1. **Financial Performance**
Operating cash outflow improved to $(0.16) million, a substantial reduction from $(2.98) million in Q1 FY26, driven by 31.5% quarter-on-quarter (QoQ) revenue growth and cost-cutting measures.
Customer cash receipts rose to $5.10 million, up from $4.54 million in Q1 FY26.
Total revenue increased to $7.1 million, with IP Licensing revenue surging by 1,000% to $3.3 million, offsetting a 25.5% decline in Brands revenue to $3.8 million due to strategic consolidation of non-core assets.
Gross profit grew by 16.7% to $2.1 million.
2. **Cash Position**
Quarter-end cash balance increased to $0.98 million, with $2.01 million in undrawn financing facilities available.
Total financing facilities stood at $11.65 million, with $9.65 million drawn.
3. **Strategic Focus**
The company continues its turnaround strategy, focusing on core brands like Pain Away, improving cash conversion, and strengthening the balance sheet.
Manufacturing and operating cash flows normalized after a one-off raw material purchase in Q1 FY26.
4. **Corporate Updates**
Payments of $0.36 million were made to related parties for directors fees, executive remuneration, and associated costs.
The Board remains optimistic about execution and engagement across the business, with efforts to enhance margins and reduce costs.
5. **Investor Engagement**
Executive Chairman Ash Vesali will host a live investor briefing on February 2, 2026, at 11 am (AEDT).
6. **Appendix 4C Highlights**
Net cash from operating activities improved to $(0.16) million.
Financing activities contributed $0.965 million in net cash.
Estimated cash available for future operations is $2.98 million, sufficient for approximately 18.3 quarters based on current cash outflows.
Wellnex Life remains committed to its strategic goals, with a focus on profitability and sustainable growth.
Below is an HTML table comparing the financials and debt year on year based on the provided text. The table includes key metrics such as revenue, gross profit, cash balance, and debt levels for Q2 FY26 and Q1 FY26.
MetricQ2 FY26Q1 FY26% Change
Revenue
Brands$3.8 million$5.1 million(25.5%)
IP Licensing$3.3 million$0.3 million1000%
Total Revenue$7.1 million$5.4 million31.5%
Gross Profit$2.1 million$1.8 million16.7%
Operating Cash Flow$(0.16) million$(2.98) million94.6% Improvement
Customer Cash Receipts$5.10 million$4.54 million12.3%
Cash Balance (Quarter End)$0.98 millionNot ProvidedN/A
Total Debt Drawn$9.65 millionNot ProvidedN/A
Unused Financing Facilities$2.01 millionNot ProvidedN/A
### Notes: 1. **Year-on-Year Comparison**: The provided text only includes data for Q2 FY26 and Q1 FY26, so a full year-on-year comparison is not possible. The table compares the two quarters instead. 2. **Debt and Cash Balance**: The debt and cash balance figures are based on the information provided in the Appendix 4C and the main text. 3. **Percentage Changes**: Calculated based on the available data for Q2 FY26 and Q1 FY26. This table provides a clear comparison of key financial metrics between Q2 FY26 and Q1 FY26, highlighting improvements and changes in revenue, cash flow, and debt levels.
WNX 06:01
Wellnex Life Limited
Market Update
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary**
Wellnex Life Limited (ASX/AIMWNX) released a market update on January 16, 2026, highlighting significant financial and operational improvements in the first half of FY26 (H1 FY26). Key achievements include
1. **Financial Performance**
H1 FY26 EBITDA improved by $2.4 million compared to the prior year.
Gross margin increased from 22.8% to 31.3%.
December 2025 EBITDA rose by $0.7 million year-on-year, driven by reduced operating costs.
The company operated at breakeven by the end of Q2 FY26.
2. **Pain Away Brand**
Quarterly sales in Q2 FY26 reached $3.3 million, with a 7.6% improvement in gross margin.
Market share gains in Australia, with heat patches and roll-ons outperforming category growth.
New distribution partnerships secured, including Priceline and major pharmacy wholesalers, with upcoming launches at Costco Australia and New Zealand.
3. **Operational Focus**
Simplified operations and cost discipline measures have stabilized the business.
Contract manufacturing is being optimized for better productivity and sustainability.
4. **Outlook**
Wellnex enters H2 FY26 with improved stability and a clear turnaround trajectory.
The company remains focused on consistent performance and long-term shareholder value creation.
Executive Chairman Ash Vesali emphasized the company’s progress and commitment to sustainable growth, positioning Wellnex for continued success in 2026.
Below is the HTML table code comparing the financials and debt year-on-year based on the provided text. Since the text does not explicitly mention debt figures, the table focuses on the financial metrics provided (EBITDA, Gross Margin, and Pain Away Sales).
MetricH1 FY26H1 FY25ChangeDecember 2025December 2024Change
EBITDAImproved by $2.4 millionNot specified+$2.4 millionUp $0.7 millionNot specified+$0.7 million
Gross Margin31.3%22.8%+8.5%Not specified (improvement sustained from November 2025)
Pain Away Sales (Q2)$3.3 millionNot specifiedNot specifiedNot specified (gross margin improved by 7.6%)
Operating Position (Q2 FY26)BreakevenNot specifiedNot specified
### Notes: 1. **Debt**: The provided text does not include specific debt figures, so the table omits debt comparisons. 2. **Metrics**: The table includes EBITDA, Gross Margin, Pain Away Sales, and Operating Position as these are the key financial metrics mentioned in the text. 3. **Changes**: Where specific numerical changes are provided (e.g., EBITDA improvement of $2.4 million), they are included in the table. 4. **Not Specified**: Fields marked "Not specified" indicate that the prior year's data or specific comparison is not provided in the text. This table can be directly embedded into an HTML document for display.
WNX 06:56
Wellnex Life Limited
Director/PDMR Shareholding

Today's AI

Today's AI Starts With News

1 live catalyst is opening Today’s AI for WNX.

Start with the live headline tape first. Today’s AI findings sit next, and the AI Blend stack drops lower once the news context is framed. Financial Forecastist now feeds the blend too.
Live Tape Data 2026-01-29 Blend Lower Down
Read the alert tape first, then open Today’s AI findings. Use AI Expand on any card to open the AI explanation, results tables and financial forecast rows instantly.
1 Today
Front Of Desk
Wellnex Life Limited has fresh news flow live now, so Today’s AI is leading with the tape before the blended signal stack below.
Single-Ticker Today's AI
WNX signal theatre built from scored market catalysts, automated AI forecasts, financial forecasting and live trigger logic.

This is the ticker-specific Today’s AI desk for Wellnex Life Limited. It compresses the live catalyst tape, bullish and bearish scoring, AI price forecasts, financial forecasting and trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI + Financial Blend Buy / Sell Trigger Engine Today's AI Findings
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full WNX Today’s AI cockpit.

Subscription turns this tab into a live signal desk with today’s news findings at the top, AI plus financial blend comparisons at the bottom, buy and sell trigger logic, and the full findings ledger behind every scored row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific Today’s AI stack, sentiment gauges, AI blend stage, and the full findings ledger for WNX on 2026-01-29.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
4.0M
Enterprise Value
-
Public Float
54.4
Broker Target
-
Shares Out
73.0M
Long Interest
-
Short Interest
-
Exchange
-
Currency Code
-
ISIN
AU0000162281
Market
None
Sector
Unknown
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

News And Alerts First

1 live alert now opens the financials desk for WNX.

Start with the headline flow and alert tape first. Then drop straight into Financial Forecastist below for the revenue path, EPS shape, cash pressure and balance-sheet read while the catalyst context is still hot.
Live Alerts Data 2026-01-29 Forecastist Below
Read the alert tape first, then move into Financial Forecastist below. Use AI Expand on any catalyst card to open the AI explanation and results tables without losing the ticker context.
1 Alerts
Front Of Desk
Wellnex Life Limited has fresh filing flow live now, so the tape is framing the revenue, leverage and valuation story below.
Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
-
Ex Divi
2009-01-01
Earnings Date
-
Net Debt
9.7M
Cash
903.0K
EPS
-0.16
Net Income
-14.7M
Revenue
16.9M
Enterprise Value
-
Trailing PE
-
Forward PE
-
Price Sales TTM
0.1634
Price Book MRQ
0.7541
EV Revenue
0.6012
EV EBITDA
-
Financial Forecastist

Mixed financial engine

Run the upgraded fundamentals refresh to populate annual and quarterly financial statement history here.

Current Ratio 0.35x
Mixed
Quarter Revenue
-
-
vs prior comparable quarter
Net Margin
-
-
profitability pulse
Free Cash Flow
-
-
cash conversion
Net Debt / EBITDA
-
-
lower is cleaner
Revenue Engine

Quarterly revenue history has not been populated yet.

Profit Stack

Profitability history is not loaded yet.

Balance-Sheet Pressure

Leverage history is not loaded yet.

Quarterly Revenue Runway

Actual revenue bars, consensus revenue where available, plus the terminal model path.

Profit And Cash Conversion

Net income and free cash flow moving together is usually what separates genuine improvement from noise.

Balance-Sheet Pressure

Cash, net debt and liquidity tell us whether the business is strengthening or just surviving.

Annual Power Curve

Longer-cycle revenue and net income help frame whether the company is compounding or rolling over.
FY 2025
Model
22.4M
Revenue Path
-
EPS / Earnings
Growth cue -
FY 2026
Model
27.9M
Revenue Path
-
EPS / Earnings
Growth cue -

Quarterly Statement Tape

Last 6 Quarters
Period Revenue Net Income FCF Net Debt
Q2 2024 - - - 9.7M

Annual Financial Power

Last 5 Years
Period Revenue Net Income EBITDA FCF
FY 2024 16.9M -14.7M - -6.9M
FY 2023 27.9M -13.8M - -6.2M
FY 2022 18.6M -7.4M - -8.7M
FY 2021 1.2M -25.0M - -5.2M

Structure DNA

Market Structure DNA

Balanced Structure profile with trend mixed

Price is 9.5% through the 52-week range, +66.4% vs 50DMA and -37.4% vs 200DMA. 29.4% of the register is locked by institutions and insiders, leaving 70.6% free float. Capital rhythm reads no cadence with forward yield near 0.0% and payout around 0.0%.

Trend mixed Institutional gravity Moderate income rhythm As Of 2026-04-19
Balanced Structure
Structure Score
45.5 / 100
Balanced Structure
Trend Stack
+66.4% / -37.4%
vs 50DMA / 200DMA
52W Position
9.5%
auction position inside the yearly range
Ownership Lock
29.4%
7.5% institutions | 21.9% insiders
Pressure Pocket
70.6% free float
Vendor short-float fields were not supplied
Capital Rhythm
No cadence
Yield 0.0% | payout 0.0%
Trend Runway

Implied spot is 5.50 with the stock +66.4% vs 50DMA and -37.4% vs 200DMA. The tape is sitting 9.5% through the 52-week range, which frames the regime as trend mixed.

Ownership Register

Institutions hold about 7.5% and insiders about 21.9%, locking roughly 29.4% of the register and leaving 70.6% in free float. That reads as institutional gravity.

Pressure Pocket

The API did not return a usable short-float field for this ticker, so the pressure score leans more on float lock and crowding than a full short ledger.

Capital Rhythm

Dividend cadence reads no cadence with - event(s) in the last full year, a five-year average of -, and stability score 0.0/100. Forward yield sits near 0.0% while payout is around 0.0%.

Structure Score

One-glance gauge for the current market-structure regime.

Pillar Radar

Trend, ownership, pressure, and capital rhythm mapped on one wheel.

Position And Float Balance

Shows whether the stock is extended, tightly held, or carrying capital-return support.

Dividend Cadence Tape

Historical dividend-event counts help reveal how dependable the income rhythm has been.

Dividend Cadence Ledger

No cadence
Year Dividend Count Context
Dividend history has not been normalized yet.

Structure Facts

Live Snapshot
Implied Spot
5.50
derived from market cap / shares
52W High
10.25
upper auction edge
52W Low
5.00
lower auction edge
Beta
1.26
volatility character
Shares Out
73.0M
fully diluted count
Shares Float
39.7M
tradable register
Shares Short
0
borrowed stock
Short Ratio
0.0x
days-to-cover style read
Ex-Dividend
-
next ex-date not supplied
Dividend Pay
-
payment date not supplied
Last Split
-
split date not supplied

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
73026812
Public Hands
54.42
Institutions
-
Institutions As Of
-
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
0
Sale Director Dealing
0
Purchase TR1
3
Sale TR1
0
Broker Coverage Rows
0
Institution Holders Tracked
0
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

News And Alerts First

The alert tape opens the door for WNX, and AI Charts sits just below.

Start with the headline flow and live catalyst tape first. Then move straight into AI Charts below for price reaction, AI targets, chart structure and catalyst beacons while the news context is still hot.
Live Tape Data 2026-01-29 AI Charts Below
Read the alert tape first, then move into AI Charts below. Use AI Expand on any catalyst card to open the AI explanation and results tables instantly.
1 Today
Catalyst Pulse
Wellnex Life Limited has fresh news flow live now, so the tape is framing the chart workspace below.
AI Charts Studio
WNX Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2026-01-29 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
Desk Snapshot Member Login
Indicators0
Technicals0
RSI Gauge
Price Change
AI Forecast